Do Analysts Agree Thursday on Xenetic Biosciences Inc (XBIO) Stock's Target Price?

Thursday, May 18, 2023 01:00 PM | InvestorsObserver Analysts

Mentioned in this article

Do Analysts Agree Thursday on Xenetic Biosciences Inc (XBIO) Stock's Target Price?

InvestorsObserver is giving Xenetic Biosciences Inc (XBIO) an Analyst Rating Rank of 5, meaning XBIO is ranked higher by analysts than 5% of stocks. The average price target for XBIO is $40 and analyst’s rate the stock as a Hold.

Wall Street analysts are rating XBIO a Hold today. Find out what this means to you and get the rest of the rankings on XBIO!

See Full XBIO Report

Why are Analyst Ratings Important?

Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve. InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.

What's Happening With Xenetic Biosciences Inc Stock Today?

Xenetic Biosciences Inc (XBIO) stock is lower by -7.64% while the S&P 500 is higher by 0.19% as of 12:56 PM on Thursday, May 18. XBIO is down -$0.22 from the previous closing price of $2.88 on volume of 12,749 shares. Over the past year the S&P 500 is higher by 6.19% while XBIO is down -65.45%. XBIO lost -$4.61 per share the over the last 12 months. Click Here to get the full Stock Report for Xenetic Biosciences Inc stock.